ストックスクリーナーアプリを入手
2.45
11.87%
0.26
アフターアワーズ：
2.46
0.010
+0.41%
前日終値:
$2.19
開ける：
$2.19
24時間の取引高:
150.73K
Relative Volume:
1.24
時価総額：
$20.74M
収益：
$2.05M
当期純損益:
$-27.28M
株価収益率:
-0.4253
EPS:
-5.76
ネットキャッシュフロー:
$-18.89M
1週間 パフォーマンス:
+13.95%
1か月 パフォーマンス:
-20.71%
6か月 パフォーマンス:
+5.15%
1年 パフォーマンス:
+818.98%
1日の値動き範囲:
$2.19
$2.46
1週間の範囲:
$2.0646
$2.46
52週間の値動き範囲:
$0.20
$4.98
iBio Inc Stock (IBIO) Company Profile
IBIO を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
| IBIO | 2.45 | 20.74M | 2.05M | -27.28M | -18.89M | -5.76 |
| VRTX | 450.37 | 115.43B | 10.63B | -479.80M | -1.35B | 13.33 |
| REGN | 744.50 | 82.04B | 13.85B | 4.65B | 3.32B | 35.06 |
| ARGX | 596.74 | 35.30B | 1.86B | -40.29M | -1.28B | -4.16 |
| ALNY | 246.80 | 32.04B | 2.09B | -332.26M | 16.06M | -4.14 |
| BNTX | 108.23 | 24.89B | 3.30B | -501.07M | 1.03B | 11.54 |
iBio Inc Stock (IBIO) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2021-11-29 | 開始されました | JMP Securities | Mkt Outperform |
| 2021-01-22 | 開始されました | Cantor Fitzgerald | Overweight |
| 2020-06-26 | 開始されました | Alliance Global Partners | Buy |
iBio Inc (IBIO) 最新ニュース
iBio Inc. stock falls Wednesday, underperforms market - MarketWatch
iBio Inc. stock rises Tuesday, outperforms market - MarketWatch
iBio Inc. stock rises Friday, outperforms market - MarketWatch
Ikarian Capital, LLC Adjusts Stake in iBio Inc - GuruFocus.com
ADAR1 Capital Management's Strategic Acquisition in iBio Inc - GuruFocus.com
iBio Inc. stock falls Thursday, underperforms market - MarketWatch
iBio Inc Reports Fiscal Q1 GAAP EPS of -$0.52, Missing Estimates; No Revenue Reported, Aligning with Expectations - GuruFocus.com
iBio Inc. stock falls Tuesday, underperforms market - MarketWatch
iBio Reports Fiscal First Quarter 2025 Financial Results - GlobeNewswire
iBio (NYSE:IBIO) Trading Down 0.6% – Here’s What Happened - Defense World
iBio Inc. stock remains steady Monday, underperforms market - MarketWatch
iBio Inc. stock rises Monday, outperforms market - MarketWatch
iBio Unveils AI-Driven Antibody Discovery Strategy - TipRanks
Plant-Based Vaccines Market Is Booming Worldwide 2024-2031 | - openPR
iBio Inc. stock remains steady Thursday, underperforms market - MarketWatch
iBio Inc. stock rises Wednesday, outperforms market - MarketWatch
iBio Inc. stock falls Monday, underperforms market - MarketWatch
Biopharmaceuticals Contract Manufacturing Industry Research 2024-2030: Biopharma Giants Increasingly Outsource to Streamline Drug Developments - GlobeNewswire Inc.
Lead molecule identified under Ibio and Astralbio’s myostatin program for obesity - BioWorld Online
Items Tagged with 'Astralbio Inc.' - BioWorld Online
iBio and AstralBio Provide Update on Myostatin Program for Obesity - GlobeNewswire
IBio, Inc. and AstralBio Provide Update on Myostatin Program for Obesity - Marketscreener.com
IBIO’s Market Seesaw: Yearly Gains & Recent Declines – What to Expect? - The InvestChronicle
What is going on with iBio Inc? Sentiment Analysis - US Post News
iBio Inc. stock falls Friday, underperforms market - MarketWatch
iBio Inc. stock rises Thursday, outperforms market - MarketWatch
iBio (NYSE:IBIO) Trading 1.6% Higher - Defense World
Inogen: Upside Seems Limited After Big Move Up (NASDAQ:INGN) - Seeking Alpha
Biafra: Why We Ended Nnamdi Kanu’s Trial – Lawyer Ejimakor - Tori.ng
Analytical Overview: ImmunityBio Inc (IBRX)’s Ratios Tell a Financial Story - The Dwinnex
Immunome (NASDAQ:IMNM) Shares Down 5.6% After Insider Selling - MarketBeat
IOVA’s price-to-free cash flow ratio: How it affects investment decisions - US Post News
iBio Inc (IBIO) 財務データ
収益
当期純利益
現金流量
EPS
0.93%
3.56%
大文字化:
|
ボリューム (24 時間):